Antifungal Drug Recalled for Manufacturing Process Deviations
Pharmadel LLC is recalling CURA HONGOS 1% Clotrimazole topical lotion due to Current Good Manufacturing Practice (CGMP) deviations identified during production. The voluntary recall affects approximately 10,128 bottles distributed in Delaware and North Carolina.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is FDA Class II with no reported illnesses or injuries. The hazard (CGMP deviations) is a manufacturing process issue without documented adverse health consequences, fitting the criteria for Moderate severity.
Plain-English summary
Pharmadel LLC, New Castle, Delaware, is voluntarily recalling CURA HONGOS Antifungal 1% Clotrimazole Topical Lotion (0.76 fl oz / 22.5 mL bottles) due to Current Good Manufacturing Practice (CGMP) deviations discovered in the manufacturing process. The product is made in India by KENIL HEALTHCARE PRIVATE LIMITED.
The recalled product includes Lot SP31A with an expiration date of 09/30/2026, and approximately 10,128 bottles were distributed to Delaware and North Carolina. The FDA classified this as a Class II recall on May 19, 2025, and the firm initiated the recall on April 24, 2025.
Consumers who have purchased this product should stop using it. No illnesses or injuries related to this recall have been reported. Consumers with questions may contact the recalling firm or their healthcare provider for further guidance.
The recalled product
- Product
- CURA HONGOS, Antifungal, 1% Clotrimazole, Topical Lotion, 0.76 fl oz (22.5 mL) Bottle, Dist by/por: Pharmadel LLC, New Castle, DE 19720, Made in India, NDC 55758-34-01, UPC 8 10096 77170 4.
- Manufacturer
- KENIL HEALTHCARE PRIVATE LIMITED
- Category
- Drug — Topical Antifungal
- Affected units
- 10,128
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot SP31A
- Exp Date: 09/30/2026
Distribution
Part of a larger recall action
This product is one of 20 recalled by KENIL HEALTHCARE PRIVATE LIMITED under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 20 products in this recall →Related recalls
Same manufacturer · KENIL HEALTHCARE PRIVATE LIMITED
See all →- ModerateNature Mint Anticavity Fluoride Toothpaste Recall CGMP Deviations
FDA (Drugs) · 2025-05-28
- ModerateMaximum Security Anticavity Gel Toothpaste recalled for CGMP deviations
FDA (Drugs) · 2025-05-28
- ModerateNature Mint Anticavity Fluoride Toothpaste Recall Due to CGMP Deviations
FDA (Drugs) · 2025-05-28
- ModerateRapidol Hydrocortisone 1% Anti-Itch Cream Recalled for CGMP Deviations
FDA (Drugs) · 2025-05-28
- ModerateNature Mint Anticavity Fluoride Toothpaste Recalled for CGMP Deviations
FDA (Drugs) · 2025-05-28
Same hazard · manufacturing process deviation
See all →- ModerateArtridon Topical Analgesic Recalled for Manufacturing Process Deviations
FDA (Drugs) · 2025-05-28
- ModerateProchlorperazine Maleate Tablets Recalled for Manufacturing Process Deviations
FDA (Drugs) · 2025-04-16
- ModerateTERUMO HydroPearl embolization microspheres recalled for manufacturing process deviation
FDA (Devices) · 2024-02-07
- ModerateAripiprazole Tablets Recalled Following FDA Inspection for Manufacturing Deviations
FDA (Drugs) · 2023-03-08
- ModerateAntacid Suspension Recalled Due to Manufacturing Process Control Deviations
FDA (Drugs) · 2022-09-14